SU1261670A1 - Method of treatment of patients ill with chronic furunculosis - Google Patents
Method of treatment of patients ill with chronic furunculosis Download PDFInfo
- Publication number
- SU1261670A1 SU1261670A1 SU833690235A SU3690235A SU1261670A1 SU 1261670 A1 SU1261670 A1 SU 1261670A1 SU 833690235 A SU833690235 A SU 833690235A SU 3690235 A SU3690235 A SU 3690235A SU 1261670 A1 SU1261670 A1 SU 1261670A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- treatment
- furunculosis
- chronic
- chronic furunculosis
- alg
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относитс к медицине и может быть использовано дл лечени больных хроническим фурункулезом. Цель изобретени - сокращение сроков лечени и числа рецидивов. Больному еженедельно в область внутренних поверхностей предплечий и передних поверхностей бедер ввод т внутрикожно в количестве 0,03- 0,07 мл антилимфоцитарный иммуноглобулин (АЛГ) в сочетании со стафилококковым анатоксином и декамевитом одновременно. 1 табл.This invention relates to medicine and can be used to treat patients with chronic furunculosis. The purpose of the invention is to reduce the duration of treatment and the number of relapses. A weekly patient is administered intracutaneously in the area of the inner surfaces of the forearm and the front of the thighs in an amount of 0.03-0.07 ml of anti-lymphocytic immunoglobulin (ALG) in combination with staphylococcal toxoid and decamevitis. 1 tab.
Description
(Л(L
СWITH
гоgo
О) 05O) 05
Изобретение относитс к медицине и может быть использовано дл лечени больных хроническим фурункулезом.This invention relates to medicine and can be used to treat patients with chronic furunculosis.
Целью изобретени вл етс сокращение сроков лечени и числа рецидивов путем терапии за счет совместного введени антилимфоцитарного иммуноглобулина (АЛГ) и стафилококкового анатоксина по определенной схеме.The aim of the invention is to reduce the duration of treatment and the number of relapses by therapy due to the joint administration of anti-lymphocytic immunoglobulin (ALG) and staphylococcal toxoid according to a definite pattern.
Способ осуществл етс следующим образом .The method is carried out as follows.
АЛГ ввод т внутрикожно в количестве 0,03-0,07 мл еженедельно в область внутренних поверхностей предплечий и передних поверхностей бедер в сочетании со стафилококковым анатоксином и декамевитом одновременно.The ALG is administered intracutaneously in an amount of 0.03-0.07 ml weekly in the area of the inner surfaces of the forearm and the front surfaces of the thighs in combination with staphylococcal toxoid and decamevitis simultaneously.
Пример. Больной А., 21 год. Диагноз: хронический фурункулез. Непрерывно возникающие множественные фурункулы.Example. Patient A., 21 years old. Diagnosis: chronic furunculosis. Continuously arising multiple boils.
Лечение: АЛГ 0,05 мл внутрикожно I раз в 7 дней поочередно в область внутренних поверхностей предплечий и передних поверхностей бедер. На курс 4 инъекции. Декамевит по 2 драже 3 раза в день. Местно: пов зки с чистым ихтиолом, 10%-ным раствором поваренной соли, 5%-ным линиментом синтомицина в соответствующие стадии развити фурункулов.Treatment: ALG 0.05 ml intracutaneously I once every 7 days alternately in the region of the inner surfaces of the forearms and the front surfaces of the thighs. In the course of 4 injections. Dekamevit 2 tablets 3 times a day. Locally: dressings with pure ichthiol, 10% sodium chloride solution, 5% synthomycin liniment at the appropriate stages of boil development.
число больныхnumber of patients
Первые инъекции АЛГ остановили рецидив непрерывно по вл ющихс фурункулов, сократили врем существовани отдельных гнойников до 10. дней. Курс лечени , состо щий из 5 инъекций АЛГ, купировал рецидивы заболевани на прот жении 16 мес цев наблюдени , существенно повысил активность показателей хемотаксиса.The first injections of ALG stopped the relapse of continuously developing boils, reduced the time of existence of individual ulcers to 10. days. The course of treatment, consisting of 5 injections of ALG, stopped the recurrence of the disease during 16 months of observation, significantly increased the activity of chemotaxis indicators.
В таблице приведены ближайшие и отдаленные результаты лечени больных хроническим фурункулезом.The table shows the immediate and long-term results of treatment of patients with chronic furunculosis.
Способ снижает число рецидивов на одного больного в 4 раза, а частоту рецидивов при легком течении фурункулеза - в 10 раз и при т желом - более, чем в 3 раза, существенно увеличива при этом сроки ремиссии .The method reduces the number of relapses per patient by 4 times, and the frequency of relapses with a light course of furunculosis - by 10 times and with heavy more than 3 times, while significantly increasing the remission period.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU833690235A SU1261670A1 (en) | 1983-09-21 | 1983-09-21 | Method of treatment of patients ill with chronic furunculosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU833690235A SU1261670A1 (en) | 1983-09-21 | 1983-09-21 | Method of treatment of patients ill with chronic furunculosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1261670A1 true SU1261670A1 (en) | 1986-10-07 |
Family
ID=21099612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU833690235A SU1261670A1 (en) | 1983-09-21 | 1983-09-21 | Method of treatment of patients ill with chronic furunculosis |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU1261670A1 (en) |
-
1983
- 1983-09-21 SU SU833690235A patent/SU1261670A1/en active
Non-Patent Citations (1)
| Title |
|---|
| Мала медицинска энциклопеди , т. 11. М., 1969, с. 15. * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE94393T1 (en) | DOSE FORM FOR ORAL ADMINISTRATION OF HYPOGLYCAEMIC GLIPICIDE. | |
| RU95106651A (en) | Analogs of des-tyr-dinorphine and method of treatment of patient with tolerant states | |
| Malpas et al. | Rubidomycin in acute leukaemia in adults | |
| KR910005858A (en) | Fatty acid therapy | |
| SU1261670A1 (en) | Method of treatment of patients ill with chronic furunculosis | |
| Wilson | Toxic amblyopia due to chloramphenicol | |
| SU1105202A1 (en) | Method of treatment of gastric ulcer and duodenal ulcer | |
| SU1169655A1 (en) | Method of treatment of thrombolytic diseases of the artery of the extremities | |
| SU1111759A1 (en) | Method of treatment of ipotency of the patients with chronic occlusion of abdominal aorta | |
| SU1171035A1 (en) | Method of curing syphilis | |
| SU1136798A1 (en) | Method of treatment of hyperactive behavour | |
| RU2108799C1 (en) | Method of treatment of nodular erythema | |
| SU833267A1 (en) | Method of treating peptic ulcer | |
| SU429813A1 (en) | METHOD OF TREATING PULMONARY TUBERCULOSIS | |
| SU904706A1 (en) | Method of treating acne rosesea complicated by demodecosis | |
| SU1553129A1 (en) | Method of treating algomenorrhea | |
| RU1561262C (en) | Composition showing antiinflammatory activity | |
| RU93002840A (en) | METHOD OF TREATMENT OF CHRONIC PURULENT ENDOBRONHITIS | |
| RU2058140C1 (en) | Method of treatment of fingers and wrist erysipelas | |
| SU1761149A1 (en) | Method for treating radiation injuries, mainly radiation fibrosis | |
| IIDA et al. | Quinidine therapy of atrial fibrillation in a horse | |
| Innerfield | Physiological and clinical effects of buccally given proteases | |
| RU1822775C (en) | Method for treatment of trigeminal nerve neuralgia | |
| SU1507380A1 (en) | Method of treatment of hearing disorders | |
| SU1194418A1 (en) | Method of treatment of children having purulent destructive pneumonia |